Fingolimod exacerbated affective psychosis?

dc.contributor.authorFitzpatrick, A.
dc.contributor.authorClark, S.
dc.contributor.authorNewcombe, R.
dc.contributor.authorDavis, A.
dc.contributor.authorBaune, B.
dc.date.issued2013
dc.description.statementofresponsibilityAlyssa Fitzpatrick, Scott R Clark, Rowena Newcombe, Anthony Davis and Bernhard T Baune
dc.identifier.citationAustralian and New Zealand Journal of Psychiatry, 2013; 47(4):399-400
dc.identifier.doi10.1177/0004867412463090
dc.identifier.issn0004-8674
dc.identifier.issn1440-1614
dc.identifier.orcidFitzpatrick, A. [0000-0001-6219-9068]
dc.identifier.orcidClark, S. [0000-0003-1640-5611]
dc.identifier.orcidBaune, B. [0000-0001-6548-426X]
dc.identifier.urihttp://hdl.handle.net/2440/78258
dc.language.isoen
dc.publisherBlackwell Publishing Asia
dc.rightsCopyright status unknown
dc.source.urihttps://doi.org/10.1177/0004867412463090
dc.subjectHumans
dc.subjectSphingosine
dc.subjectPropylene Glycols
dc.subjectImmunosuppressive Agents
dc.subjectAffective Disorders, Psychotic
dc.subjectAdult
dc.subjectFemale
dc.subjectFingolimod Hydrochloride
dc.titleFingolimod exacerbated affective psychosis?
dc.typeJournal article
pubs.publication-statusPublished

Files